FDA Orange Book
Is there a generic for Rocklatan?
Rocklatan contains netarsudil and latanoprost. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
No. The Orange Book lists no active FDA-approved generic (ANDA) for Rocklatan (netarsudil and latanoprost). The Orange Book shows its last listed patent expires March 14, 2034.
Run it in Rivvi
Map Rocklatan and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Rocklatan products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| solution/drops, ophthalmic | 0.005%;EQ 0.02% BASE | Marketed (Rx) | None | 0 | None |
NDA 208259, held by ALCON LABORATORIES INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Rocklatan patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 9096569 | July 11, 2026 | Drug substance, Drug product | U-1524 | 208259 |
| 8450344 | July 11, 2026 | Drug substance, Drug product | U-1524 | 208259 |
| 10882840 | July 11, 2026 | Method of use | U-1524 | 208259 |
| 10532993 | July 11, 2026 | Method of use | U-1524 | 208259 |
| 11021456 | July 11, 2026 | Method of use | U-1524 | 208259 |
| 10174017 | January 27, 2030 | Drug substance, Drug product | U-1524 | 208259 |
| 11618748 | January 27, 2030 | Method of use | U-1524 | 208259 |
| 10654844 | January 27, 2030 | Drug substance, Drug product | U-1524 | 208259 |
| 11028081 | January 27, 2030 | Method of use | U-1524 | 208259 |
| 8394826 | November 10, 2030 | Drug substance, Drug product | U-1524 | 208259 |
| 9993470 | March 14, 2034 | Drug substance, Drug product | U-1524 | 208259 |
| 9931336 | March 14, 2034 | Drug substance, Drug product | U-1524 | 208259 |
| 10588901 | March 14, 2034 | Drug substance, Drug product | U-1524 | 208259 |
| 11020385 | March 14, 2034 | Method of use | U-1524 | 208259 |
| 11185538 | March 14, 2034 | Drug product | None | 208259 |
| 11197853 | March 14, 2034 | Drug product | None | 208259 |
| 9415043 | March 14, 2034 | Drug substance | None | 208259 |
Rocklatan NDC codes
Questions
Is there a generic for Rocklatan?
No. The Orange Book lists no active FDA-approved generic (ANDA) for Rocklatan (netarsudil and latanoprost). The Orange Book shows its last listed patent expires March 14, 2034.
What is the generic name for Rocklatan?
The active ingredient in Rocklatan is netarsudil and latanoprost, per the FDA Orange Book.
When does the Rocklatan patent expire?
The last patent listed for Rocklatan in the Orange Book expires March 14, 2034. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.